C Colgate-Palmolive Co.
| Market Cap | $68.31B |
| P/E Ratio | 32.37 |
| Forward P/E | 20.59 |
| Dividend Yield | 2.49% |
| Beta | 0.33 |
| 52W Range | $74.52 - $99.14 |
| # Hedge Funds | 7 |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
Hedge Fund Ownership
| Investor 7 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 1.10% | $625.76M | 7,918,979 | Add 0.38% |
| Yacktman Asset Management Yacktman Asset Management | 0.87% | $62.21M | 787,300 | Reduce 0.83% |
| Jensen Investment Management Jensen Investment Management | 0.15% | $9.40M | 118,934 | Reduce 4.69% |
| FPA Queens Road Small Cap Value Fund Bragg Financial Advisors | 0.04% | $1.21M | 15,300 | Reduce 8.53% |
| Lindsell Train Lindsell Train Ltd | 0.03% | $1.15M | 14,600 | Reduce 2.67% |
| Lee Ainslie Maverick Capital | 0.01% | $764.00K | 9,670 | Reduce 67.31% |
| Dodge & Cox Dodge & Cox | 0.00% | $1.11M | 14,000 | — |
Insider Trading
| Insider Name of the company insider who made the trade 15 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin | Sale | 15,000 | $97.81 | $1.47M | 12 Feb 2026 | 13 Feb 2026 |
| Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin | Sale | 35,000 | $94.61 | $3.31M | 11 Feb 2026 | 13 Feb 2026 |
| Hazlin JohnChief Growth Officer | Sale | 20,989 | $94.25 | $1.98M | 10 Feb 2026 | 12 Feb 2026 |
| Malcolm GregoryEVP and Controller | Sale | 12,747 | $94.91 | $1.21M | 06 Feb 2026 | 10 Feb 2026 |
| Gregory MalcolmEVP and Controller | Sale | 12,747 | $94.91 | $1.21M | 06 Feb 2026 | 10 Feb 2026 |
| Massey SallyChief Human Resources Officer | Sale | 15,851 | $95.03 | $1.51M | 05 Feb 2026 | 09 Feb 2026 |
| Sally MasseyChief Human Resources Officer | Sale | 15,851 | $95.03 | $1.51M | 05 Feb 2026 | 09 Feb 2026 |
| Daniels JenniferCLO and Secretary | Sale | 22,000 | $94.34 | $2.08M | 04 Feb 2026 | 06 Feb 2026 |
| SUTULA STANLEY J IIIChief Financial Officer | Sale | 97,843 | $94.27 | $9.22M | 04 Feb 2026 | 06 Feb 2026 |
| Wallace Noel R.Chairman, President & CEO | Sale | 45,568 | $93.91 | $4.28M | 04 Feb 2026 | 06 Feb 2026 |
| Noel R. WallaceChairman, President & CEO | Sale | 45,568 | $93.91 | $4.28M | 04 Feb 2026 | 06 Feb 2026 |
| Stanley J Sutula IIIChief Financial Officer | Sale | 97,843 | $94.27 | $9.22M | 04 Feb 2026 | 06 Feb 2026 |
| Jennifer DanielsCLO and Secretary | Sale | 22,000 | $94.34 | $2.08M | 04 Feb 2026 | 06 Feb 2026 |
| Massey SallyChief Human Resources Officer | Sale | 1,237 | $80.89 | $100.06K | 21 Nov 2025 | 24 Nov 2025 |
| Sally MasseyChief Human Resources Officer | Sale | 1,237 | $80.89 | $100.06K | 21 Nov 2025 | 24 Nov 2025 |
Frequently Asked Questions
What is CL stock price today?
Colgate-Palmolive Co. (CL) is currently trading at $85.14. The stock has a 52-week range of $74.52 to $99.14 and a market capitalization of $68.31B.
Is CL a good stock to buy in 2026?
Colgate-Palmolive Co. has a P/E ratio of 32.4 (forward P/E: 20.6), a dividend yield of 2.49%, and 1-year performance of -9.1%. 7 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling CL stock?
There have been 15 insider transactions for CL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has CL stock performed over the past year?
Colgate-Palmolive Co. (CL) has returned -9.1% over the past 12 months. The stock traded between $74.52 and $99.14 during this period, and is currently at $85.14.
Which hedge funds own CL (Colgate-Palmolive Co.)?
7 tracked hedge funds currently hold CL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is CL's market cap and valuation?
Colgate-Palmolive Co. (CL) has a market capitalization of $68.31B. The trailing P/E ratio is 32.4 and forward P/E is 20.6. The stock is classified in the Consumer Defensive sector.
What is CL's revenue and profitability?
Colgate-Palmolive Co. reported revenue of $20.38B with net income of $2.13B and a profit margin of 0.10%. The stock has a beta of 0.33.
What sector is CL in and who are its biggest institutional holders?
Colgate-Palmolive Co. (CL) operates in the Consumer Defensive sector. It is held by 7 tracked hedge funds. See the ownership table above for the complete list.